Valle Franco

CIK 00016998483 companiesSAN CARLOS, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001699848

Recent Transactions

41 trades

Award
Biomea Fusion, Inc.$BMEA
Common Stock
2024-11-30$6.15/sh+495→ 42,995 total
Purchase
Biomea Fusion, Inc.$BMEA
Common Stock
2024-06-11$4.43/sh+12,509→ 42,500 total
Award
Biomea Fusion, Inc.$BMEA
Common Stock
2024-05-31$3.78/sh+4,448→ 29,991 total
Award
Biomea Fusion, Inc.$BMEA
Stock Option (Right to Buy)
2024-01-17+145,245→ 145,245 total
Award
Biomea Fusion, Inc.$BMEA
Common Stock
2023-11-30$3.78/sh+1,345→ 25,543 total
Award
Biomea Fusion, Inc.$BMEA
Common Stock
2023-05-31$3.78/sh+4,273→ 24,198 total
Award
Biomea Fusion, Inc.$BMEA
Stock Option (Right to Buy)
2023-01-06+126,300→ 126,300 total
Award
Biomea Fusion, Inc.$BMEA
Common Stock
2022-11-30$3.78/sh+2,518→ 19,925 total
Purchase
Biomea Fusion, Inc.$BMEA
Common Stock
2022-11-11$7.63/sh+4,100→ 17,407 total
Award
Biomea Fusion, Inc.$BMEA
Common Stock
2022-05-31$4.67/sh+3,307→ 13,307 total
Purchase
Biomea Fusion, Inc.$BMEA
Common Stock
2022-01-14$8.68/sh+10,000→ 10,000 total
Award
Biomea Fusion, Inc.$BMEA
Stock Option (Right to Buy)
2021-12-04+144,770→ 144,770 total
Award
Biomea Fusion, Inc.$BMEA
Stock Option (Right to Buy)
2021-08-03+165,000→ 165,000 total
Disposition to Issuer
Eidos Therapeutics, Inc.
Stock Option (Right to Buy)
2021-01-26−24,350→ 0 total
Exercise/Conversion
Eidos Therapeutics, Inc.
Stock Option (Right to Buy)
2021-01-12−1,747→ 24,350 total
Exercise/Conversion
Eidos Therapeutics, Inc.
Common Stock
2021-01-12$7.24/sh+1,747→ 1,747 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2021-01-12$125.44/sh−1,747→ 0 total
Exercise/Conversion
Eidos Therapeutics, Inc.
Stock Option (Right to Buy)
2021-01-11−1,500→ 26,097 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2021-01-11$125.61/sh−1,500→ 0 total
Exercise/Conversion
Eidos Therapeutics, Inc.
Common Stock
2021-01-11$7.24/sh+1,500→ 1,500 total
Exercise/Conversion
Eidos Therapeutics, Inc.
Common Stock
2020-11-09$7.24/sh+1,623→ 1,623 total
Exercise/Conversion
Eidos Therapeutics, Inc.
Stock Option (Right to Buy)
2020-11-09−1,623→ 27,597 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2020-11-09$74.93/sh−1,623→ 0 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2020-10-08$74.85/sh−5,199→ 0 total
Exercise/Conversion
Eidos Therapeutics, Inc.
Stock Option (Right to Buy)
2020-10-08−5,199→ 29,220 total
Exercise/Conversion
Eidos Therapeutics, Inc.
Common Stock
2020-10-08$7.24/sh+5,199→ 5,199 total
Exercise/Conversion
Eidos Therapeutics, Inc.
Common Stock
2020-10-07$7.24/sh+5,000→ 5,444 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2020-10-07$75.08/sh−5,444→ 0 total
Exercise/Conversion
Eidos Therapeutics, Inc.
Stock Option (Right to Buy)
2020-10-07−5,000→ 34,419 total
Award
Eidos Therapeutics, Inc.
Common Stock
2020-05-31$41.57/sh+444→ 444 total
Exercise/Conversion
Eidos Therapeutics, Inc.
Stock Option (right to buy)
2020-04-20−2,000→ 39,419 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2020-04-20$49.79/sh−2,000→ 0 total
Exercise/Conversion
Eidos Therapeutics, Inc.
Common Stock
2020-04-20$7.24/sh+2,000→ 2,000 total
Exercise/Conversion
Eidos Therapeutics, Inc.
Stock Option (right to buy)
2020-03-26−5,000→ 41,419 total
Exercise/Conversion
Eidos Therapeutics, Inc.
Common Stock
2020-03-26$7.24/sh+5,000→ 5,000 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2020-03-26$47.87/sh−3,000→ 2,000 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2020-03-26$48.85/sh−2,000→ 0 total
Exercise/Conversion
Eidos Therapeutics, Inc.
Common Stock
2020-03-02$7.24/sh+3,000→ 3,000 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2020-03-02$51.96/sh−2,000→ 1,000 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2020-03-02$53.06/sh−1,000→ 0 total
Exercise/Conversion
Eidos Therapeutics, Inc.
Stock Option (right to buy)
2020-03-02−3,000→ 46,419 total

Companies

Recent Filings

Address

999 SKYWAY ROAD, SUITE 150

SAN CARLOS, CA, 94070

View on SEC.gov